Skip to content

MiMedx Group MDXG Share Buybacks

Share Buybacks at other companies

IAR
Integra LifeSciencesIART
$55.25K-97.8%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$6.37M
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$1.07M-89.3%
CorMedix logo
CorMedixCRMD
$11.09M
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$809K-72.1%
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%
EPS (diluted)-$0.10-267%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total equity$216.0M-0.3%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
CapEx$598.0K+234%
Free cash flow-$10.6M-175%

Valuation

See full
Market cap$649.4M-34.1%
Enterprise value$530.77M-40.0%
P/E104.1×+73.5×
P/S1.8×-0.9×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: MiMedx Group’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's share buybacks?
MiMedx Group (MDXG) reported share buybacks of $0 in Q4 2025.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.